跳至主要内容
临床试验/EUCTR2008-008275-34-GB
EUCTR2008-008275-34-GB进行中(未招募)1 期

The Effect of Omega-3 Fatty Acids on Non-Alcoholic Fatty Liver Disease

HS Lothian0 个研究点目标入组 50 人开始时间: 2009年7月6日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • A diagnosis of non-alcoholic fatty liver disease.
  • Abnormal liver function tests.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria include: any other identified cause of chronic liver disease, the prescription of medication which would cause non-alcoholic fatty liver disease (e.g. tamoxifen), already taking supplementary fish oil, alcohol intake of >20g/day for women, >40g/ day for men, known allergy to fish oil or corn oil, on anticoagulants (antiplatelets are permitted), severe heart failure (NYHA class IV), pregnancy/ lactation, or age under 18 years.

研究者

发起方
HS Lothian

相似试验